Mojumdar, Kamalika <br/><br/>
Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2.  [electronic resource] 

 -  EMBO molecular medicine  Nov 2014 
 - 1476-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1757-4684 
<br/><br/><label>Standard No.: </label>10.15252/emmm.201403967  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Ly--analysis<br/>CD11b Antigen--analysis<br/>Chemokine CCL2--metabolism<br/>Diaphragm--pathology<br/>Female<br/>Immunotherapy--methods<br/>Male<br/>Mesenchymal Stem Cell Transplantation<br/>Mesenchymal Stem Cells--metabolism<br/>Mice, Inbred C57BL<br/>Mice, Inbred mdx<br/>Monocytes--chemistry<br/>Muscular Dystrophy, Duchenne--immunology<br/>Mutant Proteins--metabolism<br/>Receptors, CCR2--antagonists & inhibitors<br/>Treatment Outcome